When the first reported cases of A/H1N1 swine flu emerged in April 2009, it was widely believed that the novel influenza strain originated in Mexico. By late June, when evidence failed to materialize confirming a Mexican origin, a new theory hypothesized that A/H1N1 originated in Asia and was transported unintentionally via an unsuspecting human carrier to North America. This though, probably is not the case. Instead it is likely, though not confirmed, that A/H1N1, is a genetically engineered creation that originated in the United States, specifically in a lab in Madison, Wisconsin that had accidentally escaped through some kind of contamination.
The evidence for this scenario is compelling:
1. Prior to the A/H1N1 outbreak, The Institute for Molecular Virology (IMV) located in Bock Labs (administered by the University of Wisconsin-Madison) had been involved in a transmission capability study for vaccine production. This study involved reverse genetic engineering of a tissue specimen that had been extracted from a deceased Intuit woman who had succumbed to Spanish influenza that had killed up to 50 million people during the 1918-19 pandemic.
2. The current A/H1N1 version is a “highly unusual virus” never seen before that combines genetic material from North American human, avian, and swine flus and Eurasian swine flu.[1] Such a combination is unprecedented having never been found in pigs, birds, or people per The Associated Press, and likely improbable to have emerged naturally. When the fact that no close relatives of the current strain exist and IMV’s mission – to conduct virology research and training at a molecular level – is taken into account, creation through artificial genetic engineering offers the best explanation.
3. Retired Australian researcher Adrian Gibbs, who played a leading role in the development of Tamiflu®, a highly-effective anti-flu drug, theorized on May 12, 2009 that the new strain of A/H1N1 likely escaped from a laboratory setting because it exhibited characteristics “of having undergone ‘accelerated evolution’ such as what happens when flu viruses try to adapt to growth in eggs” during vaccine studies.[2] Although The World Health Organization (WHO) swiftly ruled out Mr. Gibbs’ theory a day later, it is implausible that sufficient research to ascertain a conclusion could be completed in only 24 hours.